Corona vaccine for EU and USA: Moderna applies for emergency approval

In the race for a vaccine against the corona virus, the US company Moderna seems to be ahead. According to his own statements, he has applied for emergency approval in the USA – and also in the EU.

As announced, the US pharmaceutical company Moderna was the first company to apply for approval for a corona vaccine in the EU. A corresponding application had been submitted to the European Medicines Agency Ema, confirmed a Moderna spokeswoman.

Moderna Inc. 131.28

At the same time, an application for emergency approval was filed with the US FDA. The company announced that the relevant data had been transmitted to the FDA. The FDA then scheduled an advisory committee meeting for December 17 to discuss the application.

Moderna had already announced on Monday morning that it wanted to apply for approvals on the same day. The Mainz-based manufacturer Biontech, together with the US company Pfizer, applied for emergency approval in the USA around two weeks ago. Moderna's preparation is similar to the Biontech / Pfizer vaccine in terms of its mode of action and its effectiveness.

.